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It is well established that prolonged, controlled mechanical ventilation is associated with contractile dysfunction of
the diaphragm due to impaired function of the mitochondrial respiratory chain as a result of aggravated oxidative
and nitrosative stress. Sepsis and circulatory failure induce a similar response pattern. Callahan and Supinski now
show that streptozotocin-induced insulin-dependent diabetes causes a comparable response pattern, both with
respect to function and physiology - that is, reduced fiber force and, consequently, muscle contractility - but also as
far as the underlying mechanisms are concerned. In other words, the authors elegantly demonstrate that the
consequences of a chronic metabolic disease and that of acute critical illness may lead to the same phenotype
response. It remains to be elucidated whether the underlying co-morbidity (for example, diabetes) adds to or even
synergistically enhances the effect of an acute stress situation (for example, sepsis, mechanical ventilation). In
addition, extending their previous work during shock states, the authors also show that administration of a
preparation of the enzymatic anti-oxidant superoxide dismutase can reverse the deleterious effects of diabetes.
These data are discussed in the context of the fundamental role of hyperglycemia in relation to metabolism-
dependent formation of reactive oxygen species.In this issue of Critical Care Callahan and Supinski [1]
report on the effects of insulin-dependent diabetes on
diaphragmatic function and morphology. Two weeks after
induction of insulin-dependent diabetes by injection of
streptozotocin, a drug that relatively specifically damages
pancreatic β cells due to uptake via the glucose transport
protein GLUT2, the resulting significant hyperglycemia
(430 versus 110 mg · dL−1 in the control group) led to a
one-third decrease in diaphragm mass associated with a
40% fall in specific force resulting from a comparable
reduction in single fiber force. On the cellular level, this
effect of hyperglycemia coincided with a marked increase
in oxidative and nitrosative stress as assessed by protein
carbonyls and tyrosine nitration, respectively. Injection of
polyethylene glycol (PEG) superoxide dismutase (SOD;
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2014end of the 2-week observation period) did not correct
hyperglycemia but restored muscle force in all fiber types
tested. The latter finding agrees well with nearly 20-year-old
data that the anti-oxidant N-acetylcysteine restored the
otherwise dose-dependent streptozotocin-induced impair-
ment of diaphragmatic force despite hyperglycemia being
unchanged [2]: hyperglycemia-related excess production of
reactive oxygen and nitrogen species rather than the high
glucose level per se causes diaphragmatic dysfunction
associated with insulin-dependent diabetes.
First of all, the reader may query the link between these
effects of diabetes and critical illness. It is well established
that prolonged mechanical ventilation induces contractile
dysfunction of the diaphragm [3] due to impaired function
of the mitochondrial respiratory chain as evidenced by
reduced activity of both citrate synthase and cytochrome c
oxidase associated with mitochondrial oxidative damage
[4]. Partial preservation of spontaneous respiratory activity
can at least partially attenuate the diaphragmatic contrac-
tile dysfunction, even at comparable airway pressuresLtd. The licensee has exclusive rights to distribute this article, in any medium, for
time, the article is available under the terms of the Creative Commons
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means exclusively due to mechanical ventilation: experi-
mental sepsis induced by endotoxin challenge [7] or cecal
ligation and puncture [8] caused a comparable response
pattern and, according to the pathophysiological role of
reactive oxygen species, treatment with anti-oxidants
restored normal diaphragmatic contraction [4,7-9]. The
study by Callahan and Supinski now demonstrates that
the consequences of a chronic metabolic disease and those
of acute critical illness result in the same phenotype re-
sponse. Moreover, this is true not only with respect to
function and physiology - in this case reduced fiber force
and muscle contractility - but also as far as the underlying
mechanisms are concerned - that is, impaired activity of
the mitochondrial respiratory chain due to enhanced oxi-
dative and nitrosative stress. It is obvious that this analogy
raises a subsequent question: does an underlying co-
morbidity (for example, diabetes) add to or even synergis-
tically enhance the effect of an acute stress situation (for
example, sepsis, mechanical ventilation)? Future experi-
ments may answer this question. Clearly, the time course
of the co-morbidity will assume major importance in this
context: in rats, depending on the interval between strep-
tozotocin injection and tissue sampling, diaphragmatic fa-
tigue was increased, normalized, or even attenuated [10].
What can we conclude from the present study in terms
of therapeutic consequences? Callahan and Supinski con-
vincingly demonstrate that injection of PEG SOD allowed
for a near-complete reversal of the diabetes-induced dia-
phragmatic contractile dysfunction. Thereby, the authors
extend their previous findings on the salutary effects of
PEG SOD on diaphragmatic dysfunction induced by
endotoxin, myocardial ischemia-related heart failure,
phrenic stimulation, or prolonged mechanical ventilation
as well as on endotoxin-induced cardiac dysfunction.
Given its apparent therapeutic potential during various
pathological conditions, does PEG SOD have potential for
becoming widely used during critical illness? Previously,
the equivocal role of oxygen radicals in general has been
elegantly highlighted in this journal [11], and this rad-
ical paradox assumes particular importance for SOD: its
substrate, the superoxide radical, can either initiate or
terminate oxidative stress [12]. Moreover, genetic SOD
over-expression did not affect organ dysfunction during
resuscitated murine septic shock despite enhanced anti-
oxidative capacity as demonstrated by reduced oxidative
DNA damage, most likely as a result of the lack of a paral-
lel rise in tissue activity of the downstream anti-oxidant
enzyme catalase [13]. Finally, factors other than aggra-
vated oxidative stress may also contribute to diaphrag-
matic dysfunction: sedation with propofol during well-
maintained spontaneous breathing produced the same
impairment of diaphragmatic contractility as 24 hours of
mechanical ventilation [14], and in endotoxin-challengedrats mechanical ventilation even partly restored rather
than increased diaphragmatic force generation [15]. In
both studies, the degree of diaphragmatic contractile dys-
function was not directly related to the level of oxidative
stress.
Finally, do the results of Callahan and Supinski limit
the importance of hyperglycemia as a key factor of organ
failure? Clearly, as in their previous studies, the authors
demonstrated the effectiveness of PEG SOD despite un-
changed blood glucose levels. Nevertheless, it is well
established that hyperglycemia is associated with oxida-
tive stress [16]. Moreover, the mechanical ventilation-
induced diaphragmatic contractile dysfunction was
caused by mitochondria-derived oxidative stress, which
resulted, at least in part, from a 'metabolic substrate
overflow' associated with down-regulation of 5'-adenosine
monophosphate-activated protein kinase (AMPK) [4].
Maintenance of normoglycemia attenuated mitochondrial
dysfunction and tissue apoptosis during prolonged critical
illness in rabbits [17], and in mice with resuscitated,
polymicrobial septic shock, controlling hyperglycemia im-
proved liver tissue mitochondrial respiratory activity and tis-
sue apoptosis at least in part due to AMPK activation [18].
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